TY  - JOUR
AU  - Larsen, Louise Vølund
AU  - Mirebeau-Prunier, Delphine
AU  - Imai, Tsuneo
AU  - Alvarez-Escola, Cristina
AU  - Hasse-Lazar, Kornelia
AU  - Censi, Simona
AU  - Castroneves, Luciana A
AU  - Sakurai, Akihiro
AU  - Kihara, Minoru
AU  - Horiuchi, Kiyomi
AU  - Barbu, Véronique Dorine
AU  - Borson-Chazot, Francoise
AU  - Gimenez-Roqueplo, Anne-Paule
AU  - Pigny, Pascal
AU  - Pinson, Stephane
AU  - Wohllk, Nelson
AU  - Eng, Charis
AU  - Aydogan, Berna Imge
AU  - Saranath, Dhananjaya
AU  - Dvorakova, Sarka
AU  - Castinetti, Frederic
AU  - Patocs, Attila
AU  - Bergant, Damijan
AU  - Links, Thera P
AU  - Peczkowska, Mariola
AU  - Hoff, Ana O
AU  - Mian, Caterina
AU  - Dwight, Trisha
AU  - Jarzab, Barbara
AU  - Neumann, Hartmut P H
AU  - Robledo, Mercedes
AU  - Uchino, Shinya
AU  - Barlier, Anne
AU  - Godballe, Christian
AU  - Mathiesen, Jes Sloth
AU  - Robledo Batanero, Mercedes
PY  - 2020
DO  - 10.1530/EC-20-0163
UR  - http://hdl.handle.net/20.500.12105/11345
AB  - Multiple endocrine neoplasia type 2A (MEN 2A) is a rare syndrome caused by RET germline mutations and has been associated with primary hyperparathyroidism (PHPT) in up to 30% of cases. Recommendations on RET screening in patients with apparently...
LA  - eng
PB  - Bioscientifica
KW  - MEDULLARY-THYROID CARCINOMA
KW  - RET PROTOONCOGENE
KW  - SURGICAL-MANAGEMENT
KW  - PROGNOSTIC-FACTORS
KW  - DISEASE PHENOTYPE
KW  - CODON 634
KW  - MEN 2A
KW  - MUTATIONS
KW  - PHEOCHROMOCYTOMA
KW  - PREVALENCE
TI  - Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.
TY  - journal article
ER  -